Table 5 Logistic regression model for CR-POPF occurrence in 164 matched patients
Variable | Univariate | Multivariate | |||
|---|---|---|---|---|---|
With CR-POPF, n (%) | Without CR-POPF, n (%) | P value | Relative risk (95% CI) | P value | |
PE approach | 0.034 | 0.156 | |||
End-to-side | 8 (9.8) | 74 (90.2) | 1 | ||
Duct-to-mucosa | 1 (1.2) | 81 (98.8) | 0.19 (0.02–1.88) | ||
BMI (kg/m2) | 0.090 | 0.030 | |||
< 24 | 4 (3.2) | 120 (96.8) | 1 | – | |
24–28 | 5 (13.2) | 33 (86.8) | 15.75 (2.04–121.40) | 0.008 | |
> 28 | 0 (0.0) | 2 (100.0) | 0.00 (0.00–0.00) | 1.000 | |
Diabetes | < 0.001 | 0.005 | |||
No | 3 (2.2) | 132 (97.8) | 1 | ||
Yes | 6 (20.7) | 23 (79.3) | 14.01 (2.20–89.19) | ||
Final diagnosis | 0.936 | 0.791 | |||
Pancreatic cancer | 4 (5.3) | 71 (94.7) | 1 | ||
Other pathologic findings | 5 (5.6) | 84 (94.4) | 0.71 (0.06–8.99) | ||
Pancreas texture | 0.707 | 0.817 | |||
Firm | 6 (5.0) | 113 (95.0) | 1 | ||
Soft | 3 (6.7) | 42 (93.3) | 0.75 (0.07–8.38) | ||
Pancreatic duct diameter | 0.213 | 0.114 | |||
≧ 3 mm | 6 (4.5) | 128 (95.5) | 1 | ||
< 3 mm | 3 (10.0) | 27 (90.0) | 5.39 (0.67–43.63) | ||
Neoplastic | 0.021 | ||||
No | 2 (28.6) | 5 (71.4) | 0.049 | 1 | |
Yes | 7 (4.5) | 150 (95.5) | 0.03 (0.00–0.59) | ||